Hong Kong stock anomalies | Most innovative drug concepts rise, industry welcomes the intensive release of policy dividends, BD is expected to accelerate the reassessment of innovative drugs

According to the Smart Financial APP, most of the innovative drug concepts have risen. As of the time of writing, Hutchison Medicine (01276.HK) has risen by 17.34%, with a price of 79.85 Hong Kong dollars; Shenshan Pharmaceuticals (01530.HK) has risen by 7.03%, with a price of 30.45 Hong Kong dollars; China Biopharmaceuticals (01177.HK) has risen by 6.94%, with a price of 7.24 Hong Kong dollars; Hansoh Pharmaceutical (03692) has risen by 5.54%, with a price of 36.2 Hong Kong dollars; Innovent Biologics (01801) has risen by 5.22%, with a price of 93.8 Hong Kong dollars; Sino Biopharmaceutical (02096) has risen by 5.02%, with a price of 12.96 Hong Kong dollars.